Valneva Email Format

Biotechnology ResearchPays de la Loire, France501-1000 Employees

Valneva is a specialty biotechnology company focused on developing, manufacturing, and commercializing prophylactic vaccines for infectious diseases that address unmet medical needs. Its portfolio includes multiple proprietary vaccines for travel and public health, with a track record of advancing candidates from early research through to approvals, and a positioning around first-, best-, or only-in-class vaccine solutions. The company supports a growing commercial business that helps fund its vaccine pipeline, which includes a Lyme disease vaccine candidate in advanced clinical development that is partnered with Pfizer, as well as vaccine candidates against Zika and other threats.

Sign up for free to view info

Company overview Employee directory